Page 30 of 32 · 745 questions tagged clinical-trials.
Stated plainly: dulaglutide · 37 °C. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched the…
Numbers first: dizziness · semaglutide · STEP 8. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Concretely: STEP 2 · vomiting · 1 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
For reference: orforglipron · semaglutide. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints…
For reference: dizziness · semaglutide · STEP 5. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that…
I am reading the trial table rather than the press release, which is why the numbers differ. I want to understand what this actually establishes, as opposed to what…
What I have: injection-site erythema · semaglutide · SELECT. I want to understand what this actually establishes, as opposed to what it is being used to imply. My…
The particulars: tirzepatide · SURMOUNT-5. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that…
I am asking about the protocol logic rather than about my own case specifically. I have the document in front of me and I can read the numbers. What I cannot do is…
Stated plainly: fatigue · tirzepatide · SURMOUNT-OSA. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
What I have: a GLP-1 receptor agonist · STEP 8. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I…
I have three data points across nine months, which I hope is enough to see a trend. I would like the arithmetic checked rather than the conclusion asserted. I have…
The case in front of me: SURMOUNT-2 · 15 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I am working with: 12.5 mg · mazdutide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the…
The particulars: SURMOUNT-4 · hair thinning · 15 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is…
The specifics, since they change the answer: tirzepatide · 40 °C. Somebody stated this to me confidently and I would like to check it before repeating it. I would…
Concretely: semaglutide · 37 °C. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Is there data…
What I have: STEP 3 · semaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Conditions: PIONEER-4 · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Details up front: TRIUMPH-3 · headache · 8 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Stated plainly: headache · semaglutide · STEP 5. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
What I am working with: SURMOUNT-3 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the…
Stated plainly: SURMOUNT-OSA · injection-site erythema. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
The case in front of me: STEP 1 · semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…